Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 8 | Taylor Bernadette MSr Executive Vice President | Gift | G | — 425 sh | Dec 8, 2025 |
| 8 | Beckwith Van H.EVP, Secretary and CLO | Open-market sale · 10b5-1 plan | SELL | $247K 8,854 sh | Dec 8, 2025 traded Dec 5, 2025 |
| 8 | Richard MarkPresident - Western Hemisphere | Tax withholding | F | $199K 7,383 sh | Dec 8, 2025 traded Dec 4, 2025 |
| 8 | Kuruvilla AbrahamChief Technology Officer | Disposition to issuer | D | $59K 1,283 sh | Dec 8, 2025 traded Dec 4, 2025 |
| 7 | Benzeno SharonChief Commercial Ofc Imm Med | Option exercise · 10b5-1 plan | M | — 4,290 sh | Dec 8, 2025 traded Dec 4, 2025 |
| 7 | Dines DanielDirector, CEO and Chairman, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $865K 45.0K sh | Dec 8, 2025 traded Dec 8, 2025 |
| 5 | Kuruvilla AbrahamChief Technology Officer | Disposition to issuer | D | $39K 839 sh | Dec 8, 2025 traded Dec 4, 2025 |
| 5 | Momper Sara MarieVP, CAO | Tax withholding | F | $9,024 302 sh | Dec 8, 2025 traded Dec 5, 2025 |
| 5 | Franzese Yvonne K.Chief Human Resources Officer | Tax withholding | F | $19K 475 sh | Dec 8, 2025 traded Dec 5, 2025 |
| 3 | Benzeno SharonChief Commercial Ofc Imm Med | Option exercise · 10b5-1 plan | M | — 4,157 sh | Dec 8, 2025 traded Dec 4, 2025 |
| 2 | Alpern Paul LVP and General Counsel | Option exercise · 10b5-1 plan | M | $70K 7,500 sh | Dec 8, 2025 traded Dec 4, 2025 |
| 2 | Benzeno SharonChief Commercial Ofc Imm Med | Option exercise · 10b5-1 plan | M | $52K 4,290 sh | Dec 8, 2025 traded Dec 4, 2025 |
| 2 | Beckwith Van H.EVP, Secretary and CLO | Tax withholding · 10b5-1 plan | F | $155K 5,746 sh | Dec 8, 2025 traded Dec 4, 2025 |
| 1 | Berman David MHEAD OF R&D | Option exercise · 10b5-1 plan | M | $547K 31.3K sh | Dec 8, 2025 traded Dec 4, 2025 |
| 0 | Holme TimothyCHIEF TECHNOLOGY OFFICER | Derivative conversion · 10b5-1 plan | C | — 166.4K sh | Dec 8, 2025 traded Dec 4, 2025 |
| 0 | Rizik MatthewDirector | Open-market sale · 10b5-1 plan | SELL | $48K 2,500 sh | Dec 8, 2025 traded Dec 5, 2025 |
| 0 | Alpern Paul LVP and General Counsel | Option exercise · 10b5-1 plan | M | — 7,500 sh | Dec 8, 2025 traded Dec 4, 2025 |
| 0 | Benzeno SharonChief Commercial Ofc Imm Med | Option exercise · 10b5-1 plan | M | $17K 4,157 sh | Dec 8, 2025 traded Dec 4, 2025 |
| 0 | Holme TimothyCHIEF TECHNOLOGY OFFICER | Derivative conversion · 10b5-1 plan | C | — 44.9K sh | Dec 8, 2025 traded Dec 4, 2025 |
| 0 | Berman David MHEAD OF R&D | Option exercise · 10b5-1 plan | M | $9,987 572 sh | Dec 8, 2025 traded Dec 5, 2025 |
| 0 | Berman David MHEAD OF R&D | Option exercise · 10b5-1 plan | M | — 31.3K sh | Dec 8, 2025 traded Dec 4, 2025 |
| 0 | Holme TimothyCHIEF TECHNOLOGY OFFICER | Derivative conversion · 10b5-1 plan | C | — 44.9K sh | Dec 8, 2025 traded Dec 4, 2025 |
| 0 | Berman David MHEAD OF R&D | Option exercise · 10b5-1 plan | M | — 572 sh | Dec 8, 2025 traded Dec 5, 2025 |
| 0 | Holme TimothyCHIEF TECHNOLOGY OFFICER | Derivative conversion · 10b5-1 plan | C | — 166.4K sh | Dec 8, 2025 traded Dec 4, 2025 |
| 0 | Hao XinyanChief Operating Officer | Open-market sale · 10b5-1 plan | SELL | $32K 800 sh | Dec 8, 2025 traded Dec 5, 2025 |
| 0 | Remer Eric RichardDirector, Chief Executive Officer | Tax withholding · 10b5-1 plan | F | $137K 13.8K sh | Dec 8, 2025 traded Dec 5, 2025 |
| 0 | Benzeno SharonChief Commercial Ofc Imm Med | Option exercise · 10b5-1 plan | M | $35K 4,157 sh | Dec 8, 2025 traded Dec 4, 2025 |
| 0 | Rizik MatthewDirector | Open-market sale · 10b5-1 plan | SELL | $50K 2,500 sh | Dec 8, 2025 traded Dec 4, 2025 |
| 0 | Benzeno SharonChief Commercial Ofc Imm Med | Option exercise · 10b5-1 plan | M | — 4,157 sh | Dec 8, 2025 traded Dec 4, 2025 |
| 52 | Saintil MerlineDirector | Open-market sale | SELL | $480K 10.0K sh | Dec 5, 2025 traded Dec 4, 2025 |
| 52 | Rich StuartDirector, Chief Medical Officer | Open-market purchase | BUY | $9,006 1,000 sh | Dec 5, 2025 traded Dec 2, 2025 |
| 51 | McVeety Kristen JGC and Secretary | Open-market sale · 10b5-1 plan | SELL | $105K 1,414 sh | Dec 5, 2025 traded Nov 26, 2025 |
| 48 | McVeety Kristen JGC and Secretary | Open-market sale · 10b5-1 plan | SELL | $28K 378 sh | Dec 5, 2025 traded Nov 26, 2025 |
| 47 | Neal John ScottChief Merchandising Officer | Open-market sale | SELL | $1.24M 14.6K sh | Dec 5, 2025 traded Dec 3, 2025 |
| 46 | Lee Bryan MChief Financial Officer | Open-market sale | SELL | $269K 13.2K sh | Dec 5, 2025 traded Dec 4, 2025 |
| 42 | Rich StuartDirector, Chief Medical Officer | Open-market purchase | BUY | $14K 1,500 sh | Dec 5, 2025 traded Dec 3, 2025 |
| 42 | Rich StuartDirector, Chief Medical Officer | Open-market purchase | BUY | $23K 2,500 sh | Dec 5, 2025 traded Dec 4, 2025 |
| 41 | Wilkins Edward ScottDirector | Open-market purchase | BUY | $23K 140 sh | Dec 5, 2025 traded Dec 3, 2025 |
| 41 | Intrator Michael NDirector, CEO and President, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $665K 8,405 sh | Dec 5, 2025 traded Dec 3, 2025 |
| 40 | Kieffer Tara LynnChief Product Strategy Officer | Open-market sale | SELL | $30K 2,106 sh | Dec 5, 2025 traded Dec 5, 2025 |